...ances have medicinal properties, they are considered [[Pharmaceutical drug|pharmaceuticals]].
...s Pharmacopoeia]]. In the [[European Union]], the main body that regulates pharmaceuticals is the [[European Medicines Agency|EMA]], and they enforce standards set by
...
30 KB (3,998 words) - 20:36, 8 January 2023
...re susceptible to their effects.<ref name=":7" /> The long term effects of pharmaceuticals in the environment may affect survival and reproduction of such organisms.<
...hese relations may give us more quantifiable information on the effects of pharmaceuticals in the environment.
...
32 KB (4,423 words) - 10:32, 3 January 2023
...to drugs developed to treat it is a matter of [[public policy (law)|public policy]] in many countries and has yielded medical breakthroughs that might not ot
...name="World_Medicine_2015">{{cite journal |journal=World Medical & Health Policy |date= 19 March 2015 |volume=7 |number=1 |pages= 3–27 |doi=10.1002/wmh3.131
...
34 KB (4,782 words) - 08:07, 4 January 2023
...ances have medicinal properties, they are considered [[Pharmaceutical drug|pharmaceuticals]].
...s Pharmacopoeia]]. In the [[European Union]], the main body that regulates pharmaceuticals is the [[European Medicines Agency|EMA]], and they enforce standards set by
...
46 KB (5,967 words) - 12:23, 15 November 2023
...tates, recent years have seen an increase in mass media advertisements for pharmaceuticals.
The mass marketing to users of pharmaceuticals is banned in over 30 industrialized nations, but not in the US and [[New Z
...
40 KB (5,537 words) - 08:09, 4 January 2023
...er 23, 2015|website=www.CBC.ca|access-date=March 16, 2016}}</ref> [[Turing Pharmaceuticals]] under the leadership of [[Martin Shkreli]] raised the price of the drug 5
===Public policy===
...
43 KB (5,918 words) - 08:11, 4 January 2023
*** Office of Clinical Policy and Programs
*** Office of Food Policy and Response
...
60 KB (8,770 words) - 08:38, 9 January 2023
...cies frequently require a prescription for Schedule V drugs as a matter of policy, despite their OTC status according to applicable laws and regulations. {{C
[[Category:Pharmaceuticals policy]]
...
26 KB (3,677 words) - 16:28, 3 January 2023
[[Category:Pharmaceuticals policy]]
...
21 KB (2,700 words) - 12:37, 6 January 2023
...using drug testing and [[legal drug trade|marketing of drugs]]. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a com
...induces sleep in dogs. The discovery was patented and licensed to [[Bayer pharmaceuticals]], which marketed the compound under the trade name [[Veronal]] as a sleep
...
60 KB (8,551 words) - 22:13, 8 January 2023
...harmaceutical substances |url=https://www.who.int/teams/health-product-and-policy-standards/inn/stembook&publication=who-emp-rht-tsn-2018-1 |publisher=The Wo
[[Category:Pharmaceuticals policy]]
...
25 KB (3,297 words) - 17:05, 3 January 2023
...n with various prescription and [[over-the-counter drug|over-the-counter]] pharmaceuticals, just as a customer should inform a herbalist of their consumption of actua
...[[good manufacturing practice|current good manufacturing practice]] (cGMP) policy for dietary supplements. Manufacturers of products falling into this catego
...
26 KB (3,762 words) - 10:21, 17 March 2024
...n with various prescription and [[over-the-counter drug|over-the-counter]] pharmaceuticals, just as a customer should inform a herbalist of their consumption of actua
...[[good manufacturing practice|current good manufacturing practice]] (cGMP) policy for dietary supplements. Manufacturers of products falling into this catego
...
26 KB (3,876 words) - 10:21, 17 March 2024
...journal |last=Stepp |first=John R. |title=The role of weeds as sources of pharmaceuticals |journal=[[Journal of Ethnopharmacology]] |volume=92 |issue=2–3 |pages=163–
...ns, if any, or of their safety. The World Health Organization formulated a policy on traditional medicine in 1991, and since then has published guidelines fo
...
72 KB (9,763 words) - 10:14, 3 January 2023
...RNA|siRNA]] approaches such as those conducted by [[Alnylam]] and [[Ionis Pharmaceuticals]] require non-viral delivery systems, and utilize alternative mechanisms fo
...ve-url=https://web.archive.org/web/20140902072742/http://www.dnapolicy.org/policy.international.php?action=detail&laws_id=38 |archive-date=2 September 2014 }
...
146 KB (19,273 words) - 07:50, 4 January 2023
...re is often too expensive for the average person. International healthcare policy researchers have advocated that "user fees" be removed in these areas to en
...rn medical systems. These topics generate significant political and public policy attention, particularly in the United States where healthcare is regarded a
...
65 KB (9,146 words) - 09:24, 30 July 2023
...re is often too expensive for the average person. International healthcare policy researchers have advocated that "user fees" be removed in these areas to en
...rn medical systems. These topics generate significant political and public policy attention, particularly in the United States where healthcare is regarded a
...
66 KB (9,326 words) - 09:10, 30 July 2023
...e]]s. They can be used to produce large complex molecules for use in food, pharmaceuticals, hormones, and steroids.<ref>{{cite journal|vauthors=Branduardi P, Smeraldi
...ed for non-food purposes, including the production of [[Plant manufactured pharmaceuticals|pharmaceutical agents]], [[biofuels]], and other industrially useful goods,
...
217 KB (29,051 words) - 07:55, 4 January 2023
...economic value of vaccination? |journal=Journal of Market Access & Health Policy |date=12 August 2015 |volume=3 |pages=10.3402/jmahp.v3.26964 |doi=10.3402/j
...try-specific information on vaccination policies and practices|Vaccination policy}}
...
128 KB (17,153 words) - 16:41, 3 January 2023